Table 1.
Characteristics | Patients (n = 43) |
---|---|
Median age, years (IQR) | 64 [56–70] |
Sex, male, no. (%) | 37 (86) |
Median BMI, kg/m2 (IQR) | 27 [26–30] |
Comorbidities, no. (%) | |
Hypertension | 31 (72) |
Heart failure | 1 (2.3) |
ARBS | 17 (39.5) |
Coronary disease | 5 (11.6) |
Diabetes mellitus | 16 (37.0) |
Pulmonary disease | 7 (16.0) |
Immunosuppression | 3 (7.0) |
Severity of illness | |
Duration from onset of symptoms to ICU admission, days (IQR) | 8.5 [5.3–11.6] |
SAPS II (IQR) | 37 [28–49] |
SOFA score on day 1 (IQR) | 5 [4–7] |
Acute kidney injury, no. (%) | 28 (65.1) |
KDIGO 1 | 6 (13.9) |
KDIGO 2 | 6 (13.9) |
KDIGO 3 | 16 (34.9) |
Renal replacement therapy, no. (%) | 8 (18.6) |
Mechanical ventilation on ICU admission, no. (%) | 37 (86) |
ARDS, no. (%) | 43 (100) |
Ratio of PaO2 to FiO2, mm Hg (PaO2/FiO2) at admission (IQR) | 136 [82.5–174.5] |
Ratio of PaO2 to FiO2 nadir, mm Hg (IQR) | 82 [70–103] |
Median number of prone position ventilation sessions (IQR) | 1 [0–2] |
Duration of mechanical ventilation, days (IQR) | 10 [7–12] |
Use of noradrenaline during the first 48 h, no. (%) | 36 (83.7) |
Length of stay in ICU, days (IQR) | 11 [8–13] |
Death, no. (%) | 12 (27.9) |
Admission biological data | |
WBC count, ×109 cells/L (IQR) | 9.52 [5.2–12.4] |
Lymphocyte count, ×109 cells/L (IQR) | 0.79 [0.5–1.1] |
Serum creatinine concentration, μmol/L (IQR) | 75 [57–100.5] |
D-dimers, ng/mL (IQR) | 2610 [1490–4820] |
Radiological data | |
X-ray, number of dials affected at admission | 4 [2–4] |
CT during hospitalization, no. (%) | 29 (67.4) |
10–25a | 2 (6.9) |
25–50a | 9 (31.0) |
50–75a | 10 (34.5) |
>75a | 8 (27.6) |
Antimicrobial treatment, no. (%) | |
Antibiotic therapy before admission | 29 (67.4) |
Third-generation cephalosporin | 22 (51.1) |
Macrolide | 21 (48.3) |
Other antibiotics | 11 (25.6) |
BMI = body mass index; ICU = intensive care unit; SAPS II = Simplified Acute Physiology Score II; SOFA = Sepsis-Related Organ Failure Assessment; KDIGO = Kidney Disease Improving Global Outcomes; ARDS = acute respiratory distress syndrome; ARBS = angiotensin–renin–aldosterone blocker system; WBC = white blood cells; CT = computerized tomography.
Specific COVID-19 pulmonary lesions.